Afsar U. Ahmed

Afsar U. Ahmed

Auto-generated profile, based on publicly available information

Afsar U. Ahmed

Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, 3168, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC, 3168, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Cell
Verified
Journal Article
Closed access
JVJames E. Vince
James E. Vince
Wendy WongWendy Wong
Wendy Wong
NKNufail Khan
Nufail Khan
RFRebecca Feltham
Rebecca Feltham
DCDiep Chau
Diep Chau
JSJohn Silke
John Silke

29 July 2011 in Frontiers in Biology
Verified
Journal Article
Closed access
PDF file
AAAfsar U. Ahmed
Afsar U. Ahmed

1 May 2007 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
PBPaul B. Bokko
Paul B. Bokko
LFLisa Francione
Lisa Francione
EBEsther Bandala-Sanchez
Esther Bandala-Sanchez
AAAfsar U. Ahmed
Afsar U. Ahmed
Sarah AnnesleySarah Annesley
Sarah Annesley
Paul FisherPaul Fisher
Paul Fisher
The complex cytopathology of mitochondrial diseases is usually attributed to insufficient ATP. AMP-activated protein kinase (AMPK) is a highly sensitive cellular energy sensor that is stimulated by ATP-depleting stresses. By antisense-inhibiting chaperonin 60 expression, we produced mitochondrially diseased strains with gene dose-dependent defects in phototaxis, growth, and multicellular morphogenesis. Mitochondrial disease was phenocopied in a gene dose-dependent manner by overexpressing a constitutively active AMPK α subunit (AMPKαT). The aberrant phenotypes in mitochondrially diseased strains were suppressed completely by antisense-inhibiting AMPKα expression. Phagocytosis and macropinocytosis, although energy consuming, were unaffected by mitochondrial disease and AMPKα expression levels. Consistent with the role of AMPK in energy homeostasis, mitochondrial “mass” and ATP levels were reduced by AMPKα antisense inhibition and increased by AMPKαT overexpression, but they were near normal in mitochondrially diseased cells. We also found that 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside, a pharmacological AMPK activator in mammalian cells, mimics mitochondrial disease in impairing Dictyostelium phototaxis and that AMPKα antisense-inhibited cells were resistant to this effect. The results show that diverse cytopathologies in Dictyostelium mitochondrial disease are caused by chronic AMPK signaling not by insufficient ATP.

1 October 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AAAfsar U. Ahmed
Afsar U. Ahmed
SSSoroush T. Sarvestani
Soroush T. Sarvestani
Michael GantierMichael Gantier
Michael Gantier
BWBryan Raymond George Williams
Bryan Raymond George Williams
GHGregory E. Hannigan
Gregory E. Hannigan
Integrin-linked kinase (ILK) is a ubiquitously expressed and highly conserved serine-threonine protein kinase that regulates cellular responses to a wide variety of extracellular stimuli. ILK is involved in cell-matrix interactions, cytoskeletal organization, and cell signaling. ILK signaling has also been implicated in oncogenesis and progression of cancers. However, its role in the innate immune system remains unknown. Here, we show that ILK mediates pro-inflammatory signaling in response to lipopolysaccharide (LPS). Pharmacological or genetic inhibition of ILK in mouse embryonic fibroblasts and macrophages selectively blocks LPS-induced production of the pro-inflammatory cytokine tumor necrosis factor α (TNF-α). ILK is required for LPS-induced activation of nuclear factor κB (NF-κB) and transcriptional induction of TNF-α. The modulation of LPS-induced TNF-α synthesis by ILK does not involve the classical NF-κB pathway, because IκB-α degradation and p65 nuclear translocation are both unaffected by ILK inhibition. Instead, ILK is involved in an alternative activation of NF-κB signaling by modulating the phosphorylation of p65 at Ser-536. Furthermore, ILK-mediated alternative NF-κB activation through p65 Ser-536 phosphorylation also occurs during Helicobacter pylori infection in macrophages and gastric cancer cells. Moreover, ILK is required for H. pylori-induced TNF-α secretion in macrophages. Although ILK-mediated phosphorylation of p65 at Ser-536 is independent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway during LPS stimulation, upon H. pylori infection this event is dependent on the PI3K/Akt pathway. Our findings implicate ILK as a critical regulatory molecule for the NF-κB-mediated pro-inflammatory signaling pathway, which is essential for innate immune responses against pathogenic microorganisms.

1 November 2010 in The American Journal of Pathology
Verified
Journal Article
Closed access
JRJennifer A. Ralph
Jennifer A. Ralph
AAAfsar U. Ahmed
Afsar U. Ahmed
LSLeilani L. Santos
Leilani L. Santos
ACAndrew R. Clark
Andrew R. Clark
JMJason McMorrow
Jason McMorrow
EMEric Morand
Eric Morand

1 August 2006 in Eukaryotic Cell
Verified
Journal Article
Closed access
AAAfsar U. Ahmed
Afsar U. Ahmed
PBPeter L. Beech
Peter L. Beech
SLSui T. Lay
Sui T. Lay
PGPaul R. Gilson
Paul R. Gilson
Paul FisherPaul Fisher
Paul Fisher
To investigate protein import into the mitochondria ofDictyostelium discoideum, green fluorescent protein (GFP) was fused as a reporter protein either to variable lengths of the N-terminal region of chaperonin 60 (the first 23, 40, 80, 97, and 150 amino acids) or to the mitochondrial targeting sequence of DNA topoisomerase II. The fusion proteins were expressed in AX2 cells under the actin-15 promoter. Fluorescence images of GFP transformants confirmed thatDictyosteliumchaperonin 60 is a mitochondrial protein. The level of the mitochondrially targeted GFP fusion proteins was unexpectedly much lower than the nontargeted (cytoplasmic) forms. The distinction between targeted and nontargeted protein activities was investigated at both the transcriptional and translational levels in vivo. We found that targeting GFP to the mitochondria results in reduced levels of the fusion protein even though transcription of the fusion gene and the stability of the protein are unaffected. [35S]methionine labeling and GFP immunoprecipitation confirmed that mitochondrially targeted GFP is translated at much slower rates than nontargeted GFP. The results indicate a novel phenomenon, import-associated translational inhibition, whereby protein import into the mitochondria limits the rate of translation. The simplest explanation for this is that import of the GFP fusion proteins occurs cotranslationally, i.e., protein synthesis and import into mitochondria are coupled events. Consistent with cotranslational import, Northern analysis showed that the GFP mRNA is associated with isolated mitochondria. This association occurred regardless of whether the GFP was fused to a mitochondrial leader peptide. However, the presence of an import-competent leader peptide stabilized the mRNA-mitochondria association, rendering it more resistant to extensive EDTA washing. In contrast with GFP, the mRNA of another test protein, aequorin, did not associate with the mitochondria, and its translation was unaffected by import of the encoded polypeptide into the mitochondria.